# PAR Pacific Holdings, Inc.: financial statements, quarterly

PARR · NYSE · CIK 821483 · [Energy](/sectors/energy.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/parr.md) · [Financials](/companies/parr/financials.md) · [Filings](/companies/parr/filings.md) · [Insiders](/companies/parr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/parr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,579](/filings/0000821483-24-000030.md) | [2,184 d](/filings/0000821483-26-000005.md) | [1,981](/filings/0000821483-25-000019.md) | [2,017](/filings/0000821483-25-000029.md) | [2,144](/filings/0001628280-25-049474.md) | [1,832 d](/filings/0000821483-26-000005.md) | [1,745](/filings/0000821483-26-000010.md) | [1,893](/filings/0000821483-26-000014.md) | [2,013](/filings/0001628280-25-049474.md) | [1,813 d](/filings/0000821483-26-000005.md) | [1,824](/filings/0000821483-26-000010.md) | [2,969](/filings/0000821483-26-000014.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [197](/filings/0000821483-24-000030.md) | [175 d](/filings/0000821483-26-000005.md) | [9.5](/filings/0000821483-25-000019.md) | [48.6](/filings/0000821483-25-000029.md) | [36.4](/filings/0001628280-25-049474.md) | [(47.0) d](/filings/0000821483-26-000005.md) | [(15.8)](/filings/0000821483-26-000010.md) | [96.8](/filings/0000821483-26-000014.md) | [359](/filings/0001628280-25-049474.md) | [99.3 d](/filings/0000821483-26-000005.md) | [65.3](/filings/0000821483-26-000010.md) | [635](/filings/0000821483-26-000014.md) |
| Interest expense | $m | [20.8](/filings/0000821483-23-000047.md) | [20.5 d](/filings/0000821483-24-000008.md) | [17.9](/filings/0000821483-24-000015.md) | [20.4](/filings/0000821483-25-000029.md) | [23.4](/filings/0001628280-25-049474.md) | [21.1 d](/filings/0000821483-26-000005.md) | [21.8](/filings/0000821483-26-000010.md) | [22.1](/filings/0000821483-26-000014.md) | [21.3](/filings/0001628280-25-049474.md) | [17.2 d](/filings/0000821483-26-000005.md) | [15.9](/filings/0000821483-26-000010.md) | [14.3](/filings/0000821483-26-000014.md) |
| Income tax | $m | [4.6](/filings/0000821483-24-000030.md) | [(122) d](/filings/0000821483-26-000005.md) | [(2.6)](/filings/0000821483-25-000019.md) | [6.7](/filings/0000821483-25-000029.md) | [6.5](/filings/0001628280-25-049474.md) | [(16.2) d](/filings/0000821483-26-000005.md) | [(6.9)](/filings/0000821483-26-000010.md) | [16.9](/filings/0000821483-26-000014.md) | [82.7](/filings/0001628280-25-049474.md) | [18.1 d](/filings/0000821483-26-000005.md) | [12.3](/filings/0000821483-26-000010.md) | [144](/filings/0000821483-26-000014.md) |
| Net income | $m | [171](/filings/0000821483-24-000030.md) | [289 d](/filings/0000821483-26-000005.md) | [(3.8)](/filings/0001628280-25-049474.md) | [18.6](/filings/0001628280-25-049474.md) | [7.5](/filings/0001628280-25-049474.md) | [(55.7) d](/filings/0000821483-26-000005.md) | [(30.4)](/filings/0000821483-26-000014.md) | [59.5](/filings/0000821483-26-000014.md) | [263](/filings/0001628280-25-049474.md) | [77.7 d](/filings/0000821483-26-000005.md) | [54.5](/filings/0000821483-26-000014.md) | [462](/filings/0000821483-26-000014.md) |
| Diluted EPS | $ per share | [2.79](/filings/0000821483-24-000030.md) | not reported | [(0.06)](/filings/0000821483-25-000019.md) | [0.32](/filings/0000821483-25-000029.md) | [0.13](/filings/0001628280-25-049474.md) | not reported | [(0.57)](/filings/0000821483-26-000010.md) | [1.17](/filings/0000821483-26-000014.md) | [5.16](/filings/0001628280-25-049474.md) | not reported | [1.10](/filings/0000821483-26-000010.md) | [9.35](/filings/0000821483-26-000014.md) |
| Basic EPS | $ per share | [2.85](/filings/0000821483-24-000030.md) | not reported | [(0.06)](/filings/0000821483-25-000019.md) | [0.33](/filings/0000821483-25-000029.md) | [0.13](/filings/0001628280-25-049474.md) | not reported | [(0.57)](/filings/0000821483-26-000010.md) | [1.18](/filings/0000821483-26-000014.md) | [5.29](/filings/0001628280-25-049474.md) | not reported | [1.12](/filings/0000821483-26-000010.md) | [9.53](/filings/0000821483-26-000014.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [347](/filings/0000821483-23-000047.md) | [279](/filings/0000821483-25-000010.md) | [228](/filings/0000821483-24-000015.md) | [180](/filings/0000821483-24-000022.md) | [183](/filings/0000821483-24-000030.md) | [192](/filings/0000821483-26-000005.md) | [134](/filings/0000821483-25-000019.md) | [169](/filings/0000821483-26-000014.md) | [159](/filings/0001628280-25-049474.md) | [164](/filings/0000821483-26-000014.md) | [172](/filings/0000821483-26-000010.md) | [185](/filings/0000821483-26-000014.md) |
| Current assets | $m | [2,178](/filings/0000821483-23-000047.md) | [1,989](/filings/0000821483-25-000010.md) | [1,859](/filings/0000821483-24-000015.md) | [1,976](/filings/0000821483-24-000022.md) | [1,767](/filings/0000821483-24-000030.md) | [1,772](/filings/0000821483-26-000005.md) | [1,624](/filings/0000821483-25-000019.md) | [1,720](/filings/0000821483-25-000029.md) | [1,982](/filings/0001628280-25-049474.md) | [1,776](/filings/0000821483-26-000014.md) | [2,151](/filings/0000821483-26-000010.md) | [2,454](/filings/0000821483-26-000014.md) |
| Total assets | $m | [3,889](/filings/0000821483-23-000047.md) | [3,864](/filings/0000821483-26-000005.md) | [3,772](/filings/0000821483-24-000015.md) | [3,937](/filings/0000821483-24-000022.md) | [3,853](/filings/0000821483-24-000030.md) | [3,829](/filings/0000821483-26-000005.md) | [3,753](/filings/0000821483-25-000019.md) | [3,896](/filings/0000821483-25-000029.md) | [4,077](/filings/0001628280-25-049474.md) | [3,834](/filings/0000821483-26-000014.md) | [4,210](/filings/0000821483-26-000010.md) | [4,534](/filings/0000821483-26-000014.md) |
| Current liabilities | $m | [1,940](/filings/0000821483-23-000047.md) | [1,525](/filings/0000821483-25-000010.md) | [1,448](/filings/0000821483-24-000015.md) | [1,211](/filings/0000821483-24-000022.md) | [1,046](/filings/0000821483-24-000030.md) | [1,096](/filings/0000821483-26-000005.md) | [1,042](/filings/0000821483-25-000019.md) | [1,208](/filings/0000821483-25-000029.md) | [1,309](/filings/0001628280-25-049474.md) | [1,106](/filings/0000821483-26-000014.md) | [1,325](/filings/0000821483-26-000010.md) | [1,334](/filings/0000821483-26-000014.md) |
| Total liabilities | $m | [2,817](/filings/0000821483-23-000047.md) | [2,529](/filings/0000821483-25-000010.md) | [2,460](/filings/0000821483-24-000015.md) | [2,671](/filings/0000821483-24-000022.md) | [2,599](/filings/0000821483-24-000030.md) | [2,638](/filings/0000821483-26-000005.md) | [2,641](/filings/0000821483-25-000019.md) | [2,747](/filings/0000821483-25-000029.md) | [2,681](/filings/0001628280-25-049474.md) | [2,281](/filings/0000821483-26-000014.md) | [2,658](/filings/0000821483-26-000010.md) | [2,515](/filings/0000821483-26-000014.md) |
| Long-term debt | $m | [533](/filings/0000821483-23-000047.md) | [647](/filings/0000821483-25-000010.md) | [635](/filings/0000821483-24-000015.md) | [1,055](/filings/0000821483-24-000022.md) | [1,040](/filings/0000821483-24-000030.md) | [1,108](/filings/0000821483-26-000005.md) | [1,149](/filings/0000821483-25-000019.md) | [1,108](/filings/0000821483-25-000029.md) | [962](/filings/0001628280-25-049474.md) | [798](/filings/0000821483-26-000014.md) | [943](/filings/0000821483-26-000010.md) | [738](/filings/0000821483-26-000014.md) |
| Current portion of debt | $m | [4.3](/filings/0000821483-23-000047.md) | [4.3](/filings/0000821483-25-000010.md) | [4.2](/filings/0000821483-24-000015.md) | [4.2](/filings/0000821483-24-000022.md) | [4.1](/filings/0000821483-24-000030.md) | [4.9](/filings/0000821483-26-000005.md) | [4.8](/filings/0000821483-25-000019.md) | [4.7](/filings/0000821483-25-000029.md) | [5.0](/filings/0001628280-25-049474.md) | [4.9](/filings/0000821483-26-000014.md) | [4.9](/filings/0000821483-26-000010.md) | [1.0](/filings/0000821483-26-000014.md) |
| Shareholders' equity | $m | [1,071](/filings/0000821483-24-000030.md) | [1,335](/filings/0001628280-25-049474.md) | [1,311](/filings/0001628280-25-049474.md) | [1,266](/filings/0001628280-25-049474.md) | [1,254](/filings/0001628280-25-049474.md) | [1,191](/filings/0000821483-26-000014.md) | [1,112](/filings/0000821483-26-000014.md) | [1,148](/filings/0000821483-26-000014.md) | [1,396](/filings/0001628280-25-049474.md) | [1,512](/filings/0000821483-26-000014.md) | [1,516](/filings/0000821483-26-000014.md) | [1,982](/filings/0000821483-26-000014.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [269 d](/filings/0000821483-24-000030.md) | [(2.3) d](/filings/0000821483-26-000005.md) | [25.4](/filings/0000821483-25-000019.md) | [(4.7) d](/filings/0000821483-25-000029.md) | [78.5 d](/filings/0001628280-25-049474.md) | [(15.5) d](/filings/0000821483-26-000005.md) | [(1.4)](/filings/0000821483-26-000010.md) | [134 d](/filings/0000821483-26-000014.md) | [219 d](/filings/0001628280-25-049474.md) | [93.8 d](/filings/0000821483-26-000005.md) | [(40.7)](/filings/0000821483-26-000010.md) | [283 d](/filings/0000821483-26-000014.md) |
| Capital expenditure | $m | [23.0](/filings/0000821483-23-000047.md) | [28.6 d](/filings/0000821483-26-000005.md) | [22.6](/filings/0000821483-25-000019.md) | [36.9 d](/filings/0000821483-25-000029.md) | [28.3 d](/filings/0001628280-25-049474.md) | [47.7 d](/filings/0000821483-26-000005.md) | [40.9](/filings/0000821483-26-000010.md) | [48.1 d](/filings/0000821483-26-000014.md) | [32.3 d](/filings/0001628280-25-049474.md) | [27.5 d](/filings/0000821483-26-000005.md) | [43.1](/filings/0000821483-26-000010.md) | [39.7 d](/filings/0000821483-26-000014.md) |
| Share repurchases | $m | [27.0 d](/filings/0000821483-24-000030.md) | [35.6 d](/filings/0000821483-26-000005.md) | [34.1](/filings/0000821483-25-000019.md) | [69.4 d](/filings/0000821483-25-000029.md) | [23.2 d](/filings/0001628280-25-049474.md) | [15.3 d](/filings/0000821483-26-000005.md) | [51.1](/filings/0000821483-26-000010.md) | [29.7 d](/filings/0000821483-26-000014.md) | [16.4 d](/filings/0001628280-25-049474.md) | [27.6 d](/filings/0000821483-26-000005.md) | [36.7](/filings/0000821483-26-000010.md) | [0.4 d](/filings/0000821483-26-000014.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [59.8](/filings/0000821483-23-000047.md) | [61.0](/filings/0000821483-24-000015.md) | [61.0](/filings/0000821483-24-000022.md) | [61.4](/filings/0000821483-24-000030.md) | [59.0](/filings/0000821483-25-000019.md) | [58.0](/filings/0000821483-25-000029.md) | [56.2](/filings/0001628280-25-049474.md) | [53.8](/filings/0000821483-26-000010.md) | [50.8](/filings/0000821483-26-000014.md) | [50.9](/filings/0001628280-25-049474.md) | [49.6](/filings/0000821483-26-000010.md) | [49.4](/filings/0000821483-26-000014.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 50,099,627 at 2026-07-30, from the cover of the [10-Q filed 2026-08-05](/filings/0000821483-26-000014.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.